Join

Compare · ABCL vs ABT

ABCL vs ABT

Side-by-side comparison of AbCellera Biologics Inc. (ABCL) and Abbott Laboratories (ABT): market cap, price performance, sector, and recent activity on the wire.

Summary

  • Both ABCL and ABT operate in Biotechnology: Pharmaceutical Preparations (Health Care), so they compete in similar markets.
  • ABT is the larger of the two at $155.32B, about 103.6x ABCL ($1.50B).
  • Over the past year, ABCL is up 58.9% and ABT is down 33.7% - ABCL leads by 92.6 points.
  • ABT has been more active in the news (6 items in the past 4 weeks vs 4 for ABCL).
  • ABT has more recent analyst coverage (25 ratings vs 17 for ABCL).
PerformanceABCL+58.91%ABT-33.72%
2025-06-11+0.00%2026-06-11
MetricABCLABT
Company
AbCellera Biologics Inc.
Abbott Laboratories
Price
$5.13+0.59%
$89.50+0.45%
Market cap
$1.50B
$155.32B
1M return
+3.74%
+6.09%
1Y return
+58.91%
-33.72%
Industry
Biotechnology: Pharmaceutical Preparations
Biotechnology: Pharmaceutical Preparations
Exchange
NASDAQ
NYSE
IPO
2020
News (4w)
4
6
Recent ratings
17
25
ABCL

AbCellera Biologics Inc.

AbCellera Biologics Inc. develops antibody discovery platform. Its full-stack, AI-powered drug discovery platform searches and analyzes the database of natural immune systems to find antibodies that can be developed as drugs. As of December 31, 2020, the company had 103 discovery programs that are either completed, in progress, or under contract. It has a discovery partnership agreement with Eli Lilly and Company. AbCellera Biologics Inc. was founded in 2012 and is headquartered in Vancouver, Canada.

ABT

Abbott Laboratories

Abbott Laboratories discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorder, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism, Ménière's disease and vestibular vertigo, pain, fever, inflammation, and migraine, as well as provides anti-infective clarithromycin, influenza vaccine, and products to regulate physiological rhythm of the colon. The Diagnostic Products segment offers laboratory systems in the areas of immunoassay, clinical chemistry, hematology, and transfusion; molecular diagnostics systems that automate the extraction, purification, and preparation of DNA and RNA from patient samples, as well as detect and measure infectious agents; point of care systems; cartridges for testing blood; rapid diagnostics lateral flow testing products; molecular point-of-care testing for HIV, SARS-CoV-2, influenza A and B, RSV, and strep A; cardiometabolic test systems; drug and alcohol test, and remote patient monitoring and consumer self-test systems; and informatics and automation solutions for use in laboratories. The Nutritional Products segment provides pediatric and adult nutritional products. The Medical Devices segment offers rhythm management, electrophysiology, heart failure, vascular, and structural heart devices for the treatment of cardiovascular diseases; and diabetes care products, as well as neuromodulation devices for the management of chronic pain and movement disorders. The company was founded in 1888 and is based in North Chicago, Illinois.

Latest ABCL

Latest ABT